ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants
ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions
为遭受极端天气条件影响的行作物识别了十几种新型微生物。
TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown under extreme weather conditions, including drought. While this process can normally take several years, the collaboration achieved success within its first 12 months – thanks to Lavie Bio's proprietary Biology Driven Design (BDD) technology platform.
以色列特拉维夫和雷霍沃特，2024年7月17日/ PRNewswire / - 全球领先的专业矿物质公司ICL（纽约证交所：ICL）（TASE：ICL）与领先的农业生物技术公司兼Evogene Ltd.（纳斯达克：EVGN）（TASE：EVGN）的子公司Lavie Bio Ltd.宣布了一个重大里程碑，即合作开发应对各种生物压力的关键作物的生物促进溶液。通过利用人工智能（AI），Lavie Bio已计算出十几种新微生物候选人，认为在极端天气条件下生长的作物中有商业可行性，包括干旱地区。尽管这个过程通常需要几年时间，但在第一个12个月内，合作取得了成功，这要归功于Lavie Bio的专有生物驱动设计（BDD）技术平台。